Search research articles
Contact Us
Filters
Showing results (161-170 of 724) with videos related to
Page
of 73
Sort By:
Mayo Clinic Proceedings
|
February 9, 2007
Cancer symposium for the practitioner: introduction to solid tumors
Alex A Adjei, S Vincent Rajkumar, Ayalew Tefferi
Blood Cancer Journal
|
May 29, 2026
Monoclonal gammopathy of clinical significance: a multisystem review
Manraj Singh Sra, S Vincent Rajkumar, Shaji Kumar
Blood Reviews
|
March 21, 2007
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
S Vincent Rajkumar, Martha Q Lacy, Robert A Kyle
Mayo Clinic Proceedings
|
August 6, 2020
Clinical Trial End Points in Severe COVID-19
Aakash Desai, Amit Kulkarni, S Vincent Rajkumar, et al.
Blood
|
December 28, 2018
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing
Shaji K Kumar, Francis K Buadi, S Vincent Rajkumar
Mayo Clinic Proceedings
|
October 2, 2010
Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence
S Vincent Rajkumar, Robert A Kyle, Francis K Buadi
Mayo Clinic Proceedings
|
March 6, 2017
Call for Papers on Clinical Practice Guidelines
Tom D Thacher, S Vincent Rajkumar, William L Lanier
Nature Reviews. Clinical Oncology
|
August 2, 2012
Haematological cancer: Redefining myeloma
S Vincent Rajkumar, Giampaolo Merlini, Jesus F San Miguel
The Lancet. Oncology
|
December 3, 2020
Treatments for newly diagnosed multiple myeloma: when endurance is interrupted - Authors' reply
Shaji K Kumar, Susanna J Jacobus, S Vincent Rajkumar
Blood
|
August 15, 2015
Guidelines for determination of the number of prior lines of therapy in multiple myeloma
S Vincent Rajkumar, Paul Richardson, Jesus F San Miguel
Page
of 73
Search research articles
Search
Showing results (161-170 of 724) with videos related to
Sort By:
Page
of 73
Mayo Clinic Proceedings
|
February 9, 2007
Cancer symposium for the practitioner: introduction to solid tumors
Alex A Adjei, S Vincent Rajkumar, Ayalew Tefferi
Blood Cancer Journal
|
May 29, 2026
Monoclonal gammopathy of clinical significance: a multisystem review
Manraj Singh Sra, S Vincent Rajkumar, Shaji Kumar
Blood Reviews
|
March 21, 2007
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
S Vincent Rajkumar, Martha Q Lacy, Robert A Kyle
Mayo Clinic Proceedings
|
August 6, 2020
Clinical Trial End Points in Severe COVID-19
Aakash Desai, Amit Kulkarni, S Vincent Rajkumar, et al.
Blood
|
December 28, 2018
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing
Shaji K Kumar, Francis K Buadi, S Vincent Rajkumar
Mayo Clinic Proceedings
|
October 2, 2010
Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence
S Vincent Rajkumar, Robert A Kyle, Francis K Buadi
Mayo Clinic Proceedings
|
March 6, 2017
Call for Papers on Clinical Practice Guidelines
Tom D Thacher, S Vincent Rajkumar, William L Lanier
Nature Reviews. Clinical Oncology
|
August 2, 2012
Haematological cancer: Redefining myeloma
S Vincent Rajkumar, Giampaolo Merlini, Jesus F San Miguel
The Lancet. Oncology
|
December 3, 2020
Treatments for newly diagnosed multiple myeloma: when endurance is interrupted - Authors' reply
Shaji K Kumar, Susanna J Jacobus, S Vincent Rajkumar
Blood
|
August 15, 2015
Guidelines for determination of the number of prior lines of therapy in multiple myeloma
S Vincent Rajkumar, Paul Richardson, Jesus F San Miguel
Page
of 73